Can I read Biomarkers for Alzheimer’s Disease on EtoBox?
Biomarkers for Alzheimer’s Disease by Leonardo Guzman-Martinez; Ricardo B. Maccioni; Gonzalo A. Farías; Patricio Fuentes; Leonardo P. Navarrete is a Medicine article available to read on EtoBox.
What is Biomarkers for Alzheimer’s Disease about?
## Alzheimer ́s disease (AD) and related forms of dementia are increasingly affecting the aging population throughout the world, at an alarming rate. The World Alzheimer ́s Report indicates a prevalence of 46.8 million people affected by AD worldwide. As population ages, this number is projected to triple by 2050 unless effective interventions are developed and implemented. Urgent efforts are required for an early detection of this disease. The ultimate goal is the identification of viable targets for the development of molecular markers and validation of their use for early diagnosis of AD that may improve treatment and the disease outcome in patients. The diagnosis of AD has been difficult to resolve since approaches for early and accurate detection and follow-up of AD patients at the clinical level have been reported only recently. Some proposed AD biomarkers include the detection of pathophysiological processes in the brain in vivo with new imaging techniques and novel PET ligands, and the determination of pathogenic proteins in cerebrospinal fluid showing anomalous levels of hyperphosphorylated tau and low Aβ peptide. These biomarkers have been increasingly accepted by AD diag
Who reads Biomarkers for Alzheimer’s Disease?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Leonardo Guzman-Martinez; Ricardo B. Maccioni; Gonzalo A. Farías; Patricio Fuentes; Leonardo P. Navarrete
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2019
- Language
- EN
- Field
- Medicine (Health Sciences)